Your browser doesn't support javascript.
loading
Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.
Wu, Chung-Pu; Murakami, Megumi; Wu, Yu-Shan; Chi, Ya-Chen; Hsiao, Sung-Han; Huang, Yang-Hui; Hung, Tai-Ho; Ambudkar, Suresh V.
Afiliación
  • Wu CP; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Murakami M; Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Wu YS; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei, Taiwan.
  • Chi YC; Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
  • Hsiao SH; Department of Chemistry, Tunghai University, Taichung, Taiwan.
  • Huang YH; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Hung TH; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
  • Ambudkar SV; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.
Front Cell Dev Biol ; 9: 699571, 2021.
Article en En | MEDLINE | ID: mdl-34350184
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2021 Tipo del documento: Article País de afiliación: Taiwán